Generation of allogeneic and xenogeneic functional muscle stem cells for intramuscular transplantation
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci166998 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Ajda Lenardič und 15 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Regenerative and Movement Biology, Department of Health Sciences and Technology, ETH Zurich, Schwerzenbach, Switzerland. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Induced Pluripotent Stem Cells, Satellite Cells, Skeletal Muscle. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, ETH Zurich.
Abstract (Originalsprache)
Satellite cells, the stem cells of skeletal muscle tissue, hold a remarkable regeneration capacity and therapeutic potential in regenerative medicine. However, low satellite cell yield from autologous or donor-derived muscles hinders the adoption of satellite cell transplantation for the treatment of muscle diseases, including Duchenne muscular dystrophy (DMD). To address this limitation, here we investigated whether satellite cells can be derived in allogeneic or xenogeneic animal hosts. First, injection of CRISPR/Cas9-corrected Dmd mdx mouse induced pluripotent stem cells (iPSCs) into mouse blastocysts carrying an ablation system of host satellite cells gave rise to intraspecies chimeras exclusively carrying iPSC-derived satellite cells. Furthermore, injection of genetically corrected DMD iPSCs into rat blastocysts resulted in the formation of interspecies rat-mouse chimeras harboring mouse satellite cells. Notably, iPSC-derived satellite cells or derivative myoblasts produced in intraspecies or interspecies chimeras restored dystrophin expression in DMD mice following intramuscular transplantation and contributed to the satellite cell pool. Collectively, this study demonstrates the feasibility of producing therapeutically competent stem cells across divergent animal species, raising the possibility of generating human muscle stem cells in large animals for regenerative medicine purposes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Regenerative and Movement Biology, Department of Health Sciences and Technology, ETH Zurich, Schwerzenbach, Switzerland.
- Biozentrum, University of Basel, Basel, Switzerland.
- Functional Genomics Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland.
- Laboratory of Exercise and Health, Department of Health Sciences and Technology, ETH Zurich, Schwerzenbach, Switzerland.
Förderung
- Swiss National Science Foundation
- ETH Zurich
Zitieren
APA
Lenardič, A., Domenig, S. A., Zvick, J., Bundschuh, N., Tarnowska-Sengül, M., Furrer, R., Noé, F., Trautmann, C. L., Ghosh, A., Bacchin, G., Gjonlleshaj, P., Qabrati, X., Masschelein, E., De Bock, K., Handschin, C., & Bar-Nur, O. (2024). Generation of allogeneic and xenogeneic functional muscle stem cells for intramuscular transplantation. Journal of Clinical Investigation. https://doi.org/10.1172/jci166998
Vancouver
Lenardič A, Domenig SA, Zvick J, Bundschuh N, Tarnowska-Sengül M, Furrer R, et al. Generation of allogeneic and xenogeneic functional muscle stem cells for intramuscular transplantation. Journal of Clinical Investigation. 2024. doi:10.1172/jci166998
BibTeX
@article{Lenardi2024,
author = {Lenardič, Ajda and Domenig, Seraina A and Zvick, Joel and Bundschuh, Nicola and Tarnowska-Sengül, Monika and Furrer, Regula and Noé, Falko and Trautmann, Christine L and Ghosh, Adhideb and Bacchin, Giada and Gjonlleshaj, Pjeter and Qabrati, Xhem and Masschelein, Evi and De Bock, Katrien and Handschin, Christoph and Bar-Nur, Ori},
title = {Generation of allogeneic and xenogeneic functional muscle stem cells for intramuscular transplantation},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci166998}
}
EUVIMED